Company intelligence / Profile preview

Scitara

Marlborough, Massachusetts, United Statesscitara.com ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

Scitara’s DLX and SIP platforms are commercially available, enabling cloud-based, vendor-neutral integration of laboratory instruments, applications, and informatics systems. These solutions automate data workflows, ensure regulatory compliance with built-in audit trails, and support AI/ML initiatives in R&D, bioprocessing, and quality control labs. The company has demonstrated significant reductions in manual data entry and batch release times for customers[1][4][7].

Industry: Drug Discovery Services

Partnerships

Leading instrument manufacturersInformatics vendors

Beyond the preview

Go deeper on Scitara.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scitara.

Explore the full profile